Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda A Paraskeva

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Respirology (Carlton, Vic.)|April 22, 2024
Advances in lung transplantation: 60 years onMiranda A Paraskeva, Gregory I Snell
JHLT Open|December 1, 2025
Transition from pediatric to adult care in thoracic transplantation-Challenges and opportunitiesNicole Gaffney, Melissa K Cousino, Miranda A Paraskeva
Drugs|October 22, 2013
Immunosuppression and allograft rejection following lung transplantation: evidence to dateGregory I Snell, Glen P Westall, Miranda A Paraskeva
Australian Family Physician|May 21, 2011
SpirometryMiranda A Paraskeva, Brigitte M Borg, Matthew T Naughton
Current Opinion in Organ Transplantation|August 12, 2015
Antibody-mediated rejectionGlen P Westall, Miranda A Paraskeva, Greg I Snell
Annals of Translational Medicine|May 2, 2020
An update on chronic lung allograft dysfunctionSakhee Kotecha, Miranda A Paraskeva, Kovi Levin, et al.
The Medical Journal of Australia|June 1, 2018
Lung transplantation in Australia, 1986-2018: more than 30 years in the makingMiranda A Paraskeva, Kovi C Levin, Glen P Westall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 22, 2021
Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunctionMiranda A Paraskeva, Brigitte M Borg, Eldho Paul, et al.
Journal of Cardiac Surgery|June 20, 2018
Suicide right ventricle after lung transplantation for pulmonary vascular diseaseShivanand Gangahanumaiah, Bronwyn C Scarr, Mark R Buckland, et al.
Therapeutic Drug Monitoring|January 20, 2026
Extracorporeal Membrane Oxygenation Can Affect Posaconazole Exposure in Critically Ill PatientsMing G Chai, Rekha P Mangalore, Joshua F Ihle, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Respirology (Carlton, Vic.)|April 22, 2024
Advances in lung transplantation: 60 years onMiranda A Paraskeva, Gregory I Snell
JHLT Open|December 1, 2025
Transition from pediatric to adult care in thoracic transplantation-Challenges and opportunitiesNicole Gaffney, Melissa K Cousino, Miranda A Paraskeva
Drugs|October 22, 2013
Immunosuppression and allograft rejection following lung transplantation: evidence to dateGregory I Snell, Glen P Westall, Miranda A Paraskeva
Australian Family Physician|May 21, 2011
SpirometryMiranda A Paraskeva, Brigitte M Borg, Matthew T Naughton
Current Opinion in Organ Transplantation|August 12, 2015
Antibody-mediated rejectionGlen P Westall, Miranda A Paraskeva, Greg I Snell
Annals of Translational Medicine|May 2, 2020
An update on chronic lung allograft dysfunctionSakhee Kotecha, Miranda A Paraskeva, Kovi Levin, et al.
The Medical Journal of Australia|June 1, 2018
Lung transplantation in Australia, 1986-2018: more than 30 years in the makingMiranda A Paraskeva, Kovi C Levin, Glen P Westall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 22, 2021
Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunctionMiranda A Paraskeva, Brigitte M Borg, Eldho Paul, et al.
Journal of Cardiac Surgery|June 20, 2018
Suicide right ventricle after lung transplantation for pulmonary vascular diseaseShivanand Gangahanumaiah, Bronwyn C Scarr, Mark R Buckland, et al.
Therapeutic Drug Monitoring|January 20, 2026
Extracorporeal Membrane Oxygenation Can Affect Posaconazole Exposure in Critically Ill PatientsMing G Chai, Rekha P Mangalore, Joshua F Ihle, et al.
Pageof 3